LSL Pharma Group (TSXV:LSL) Debt-to-Equity : 1.88 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Debt-to-Equity?

LSL Pharma Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$9.10 Mil. LSL Pharma Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$7.17 Mil. LSL Pharma Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$8.66 Mil. LSL Pharma Group's debt to equity for the quarter that ended in Dec. 2023 was 1.88.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for LSL Pharma Group's Debt-to-Equity or its related term are showing as below:

TSXV:LSL' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.15 Med: 1.65 Max: 2.81
Current: 1.88

During the past 4 years, the highest Debt-to-Equity Ratio of LSL Pharma Group was 2.81. The lowest was 1.15. And the median was 1.65.

TSXV:LSL's Debt-to-Equity is ranked worse than
93.99% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs TSXV:LSL: 1.88

LSL Pharma Group Debt-to-Equity Historical Data

The historical data trend for LSL Pharma Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Debt-to-Equity Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

Debt-to-Equity

1.41

1.15

2.81

1.88

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial							2.81	0.88	1.02	1.42	1.88

Competitive Comparison of LSL Pharma Group's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Debt-to-Equity falls into.

LSL Pharma Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

LSL Pharma Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.098	+	7.171)	/	8.655
	=	1.88

LSL Pharma Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.098	+	7.171)	/	8.655
	=	1.88

LSL Pharma Group (TSXV:LSL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

LSL Pharma Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines